Middle East & Africa Bioprocessing Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)

No. of Pages: 139    |    Report Code: BMIRE00030825    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Middle East & Africa Bioprocessing Market
Buy Now

The Middle East & Africa bioprocessing market was valued at US$ 314.37 million in 2023 and is expected to reach US$ 725.54 million by 2031; it is estimated to register a CAGR of 11.0% from 2023 to 2031.

Shift Toward Automated Cell Therapy Manufacturing Bolsters Middle East & Africa Bioprocessing Market



A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. Increasing research activities in cell therapies have led to a rise in the demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the needs of academic researchers and large biotechnology companies. For instance, the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. In addition, the evolution of cell therapy-from an academic and clinical setting to mass production and commercialization-is increasing the demand for automation in manufacturing. In May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice-compliant digital solution designed to optimize complex cell therapy process development and manufacturing. Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated cGMP-compliant platform (system and software) along with reagents, consumables, and instruments. In March 2019, Lonza partnered with Israel's Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform. Automated procedures can drastically reduce the production cost and enhance staff productivity and retention rates. Other than these factors, automated processes restrict various possible sources of contamination in the manufacturing unit and eventually enhance process consistency, which results in overall good quality products by reducing manual errors. Thus, the increasing adoption of automation among cell therapy manufacturers and the growing product innovations in the field of cell therapy are likely to boost cell therapy bioprocessing or manufacturing.

Middle East & Africa Bioprocessing Market Overview



The Middle East & Africa bioprocessing market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. Saudi Arabia holds the largest share of the market in the Middle East & Africa. The increasing prevalence of cancer, growing incidence of immunological disorders, favorable initiatives by governments, and an upsurge in research and development activities are a few factors driving the market in this region. Saudi Arabian ministries are signing agreements with biotech companies for establishing production facilities in the country. In line with this, expansion strategies adopted by international companies to strengthen their presence in the Middle East & Africa are expected to benefit the bioprocessing market in the upcoming years.

Middle East & Africa Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)
Get more information on this report

Middle East & Africa Bioprocessing Strategic Insights

Strategic insights for the Middle East & Africa Bioprocessing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-bioprocessing-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Bioprocessing Report Scope

Report Attribute Details
Market size in 2023 US$ 314.37 Million
Market Size by 2031 US$ 725.54 Million
Global CAGR (2023 - 2031) 11.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Instruments and Consumables & Accessories
By Scale of Operation
  • Commercial Operations and Clinical Operations
By Application
  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Protein
  • Cell & Gene Therapy
By End User
  • Biopharmaceutical Companies
  • Contract Manufacturing Organization
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Agilent Technologies Inc
  • Cytiva US LLC.
    		•
    Get more information on this report

    Middle East & Africa Bioprocessing Regional Insights

    The geographic scope of the Middle East & Africa Bioprocessing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-bioprocessing-market-geography.webp
    Get more information on this report



    Middle East & Africa Bioprocessing Market Segmentation



    The Middle East & Africa bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

    Based on product, the Middle East & Africa bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

    In terms of scale of operation, the Middle East & Africa bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

    By process, the Middle East & Africa bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

    Based on application, the Middle East & Africa bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

    In terms of end user, the Middle East & Africa bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

    By country, the Middle East & Africa bioprocessing market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioprocessing market share in 2023.

    Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Middle East & Africa bioprocessing market.

    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Bioprocessing Market

    1. Getinge AB
    2. Thermo Fisher Scientific Inc
    3. Sartorius AG
    4. Corning Inc
    5. Bio-Rad Laboratories Inc
    6. Merck KGaA
    7. 3M Co
    8. Eppendorf SE
    9. Agilent Technologies Inc
    10. Cytiva US LLC.
    Frequently Asked Questions
    How big is the Middle East & Africa Bioprocessing Market?

    The Middle East & Africa Bioprocessing Market is valued at US$ 314.37 Million in 2023, it is projected to reach US$ 725.54 Million by 2031.

    What is the CAGR for Middle East & Africa Bioprocessing Market by (2023 - 2031)?

    As per our report Middle East & Africa Bioprocessing Market, the market size is valued at US$ 314.37 Million in 2023, projecting it to reach US$ 725.54 Million by 2031. This translates to a CAGR of approximately 11.0% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Bioprocessing Market report typically cover these key segments-

    • Product (Instruments and Consumables & Accessories)
    • Scale of Operation (Commercial Operations and Clinical Operations)
    • Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy)
    • End User (Biopharmaceutical Companies, Contract Manufacturing Organization)

    What is the historic period, base year, and forecast period taken for Middle East & Africa Bioprocessing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Bioprocessing Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Middle East & Africa Bioprocessing Market?

    The Middle East & Africa Bioprocessing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Getinge AB
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Corning Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • 3M Co
  • Eppendorf SE
  • Agilent Technologies Inc
  • Cytiva US LLC.
    • Who should buy this report?

    The Middle East & Africa Bioprocessing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Bioprocessing Market value chain can benefit from the information contained in a comprehensive market report.

    middle-east-and-africa-bioprocessing-market